27th May 2016 07:56
LONDON (Alliance News) - Shareholders in Irish drugmaker Shire PLC on Friday approved the company's USD32.0 billion acquisition of US-based Baxalta Inc.
Shire said 94% of its shareholders voted in favour of the deal at a meeting Friday, paving the way for the deal to complete on June 3.
"We are pleased to take this important step toward completing our combination with Baxalta, and are grateful that our shareholders have voiced their support by approving this transaction," said Shire Chief Executive Flemming Ornskov.
"The combination will allow us to realise our goal of building the leading global biotechnology company focused on rare diseases and other highly specialised conditions, offering greater opportunities for our patients, healthcare partners and employees," he added.
Shire shares were down 0.3% to 4,335.00 pence on Friday morning.
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2016 Alliance News Limited. All Rights Reserved.
Related Shares:
Shire